Tanel Kiik
Sotsiaalminister
Sotsiaalministeerium 21.12.2020
nr 10.1-13/1247-1
Austatud härra minister
Edastame Teile Euroopa Komisjoni voliniku Stella Kyriakidese 19.12.2020 kirja nr Ares(2020)
7795830.
Lugupidamisega
Marten Kokk
Esinduse asejuht Coreper I küsimustes
Lisa: voliniku kiri 2 lehel
Kersti Neeme +32 2227 4342
[email protected]
Rue Guimard 11/13 1040 Brüssel Tel: +32 2 227 39 10
[email protected] https://eu.mfa.ee/et/
Ref. Ares(2020)7795830 - 19/12/2020
STELLA KYRIAKIDES Rue de la Loi, 200
MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels – Berl 10/380
HEALTH AND FOOD SAFETY
[email protected]
Brussels,
Dear Minister Kiik,
I hope this letter finds you, your family and colleagues in good health during these difficult
times.
I would like to thank you for your close cooperation throughout this crisis, which has allowed
us to overcome many obstacles together. Our close cooperation shows that EU solidarity is
strong and indispensable in overcoming challenges, including public health emergencies. The
work that we are doing to ensure that safe and performant medical devices are continuously
available on the market highlights the importance of this sector for the safety and health of all
Europeans. This is the case not only in times of health crises, but also in the day-to-day
functioning of health systems.
As discussed during the informal Health Ministers’ meeting of 2 December, it is now time to
turn our attention to the effective implementation of the new regulatory framework on
medical devices.
The Medical Devices Regulation (MDR), which was set to apply from 26 May 2020, was
postponed by one year as a necessary measure at an exceptional moment in time. I wish to
thank you for the very efficient inter-institutional co-operation in getting this measure
adopted so swiftly. The decision has helped to ensure that safe and essential medical devices
could continue to be placed on the EU market during COVID-19. It has also allowed the
already stretched resources of the national competent authorities, notified bodies,
manufacturers and other actors to fully prioritise and focus their efforts on the COVID-19
pandemic. Yet, there are two specific issues which remain particularly challenging:
First, the designation of notified bodies under the new regulations is an essential element of
the medical devices regulation and an extensive, intricate and demanding process, which
requires joint assessments of candidate notified bodies by experts from the Commission and
the national authorities. While we have managed to find available experts for 2020, even
under the additional constraints imposed by COVID-19 in terms of travel restrictions, it has
been a very challenging exercise.
Mr Tanel Kiik
Minister of Social Affairs
Suur-Ameerika 1,
10122 Tallinn Estonia
I hope that I can count on your continued commitment in the assessment process, including to
ensure that experts can be made available when called upon. This is essential as a lack of
assessors will result in risks of delay in the designation of notified bodies, which might have
a negative impact on the availability of medical devices on the market.
Secondly, I would like to draw your attention to the implementation of the In vitro
Diagnostic Medical Devices Regulation (IVDR). While the IVDR only applies from 26
May 2022, the work necessary to set up this system should not be underestimated. The
shift of resources and priorities to COVID-19 has inevitably had an impact on the
implementation of the IVDR. Yet, the COVID-19 situation has demonstrated the
importance of this new legal framework. While today a substantial percentage of the in
vitro diagnostic medical device tests, including for COVID-19, are self-declared by
manufacturers, the new legal framework will strengthen the rules on conformity
assessments and require the involvement of a notified body. It is therefore essential that we
take all measures possible to ensure that the implementation can advance smoothly.
The key priorities and challenges of the IVDR implementation were discussed in the
Medical Devices Coordination Group meeting on 20-21 October 2020 and again on 7-8
December 2020 where a large number of work items and challenges were identified. It will
only be possible to address these challenges and follow up on the priorities, if the
Commission, Member States and stakeholders collaborate closely together and allocate the
necessary resources. I hope I can count on your active contribution and engagement in this
important work.
Finally, I take the occasion to share with you an observation on the task forces established
under the Medical Devices Coordination Group to facilitate the implementation of the
medical device legislation. To this date, many of these task forces are lacking a lead
Member State, which reduces their effectiveness. The expertise and knowledge from a
national perspective are crucial to move the work forward and I ask, here also, for your
commitment and cooperation.
I thank you for your support and look forward to working with you to ensure the
implementation of this important legislative framework to protect the health of all.
Yours sincerely,
Electronically signed on 16/12/2020 11:27 (UTC+01) in accordance with article 11 of Commission Decision C(2020) 4482